Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 9, doi. 10.1002/pu.30874
- Publication type:
- Article
Works matching IS 10685308 AND DT 2022 AND VI 33 AND IP 5
Results: 12
1
2
Approvals.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 8, doi. 10.1002/pu.30873
- Publication type:
- Article
3
Brexpiprazole shows promising result in reducing BPD symptoms.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 8, doi. 10.1002/pu.30872
- Publication type:
- Article
4
Cannabis users' willingness to drive clashes with impaired performance.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 8, doi. 10.1002/pu.30871
- Publication type:
- Article
5
Sertraline, escitalopram fare best in review of SSRIs for panic disorder.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 6, doi. 10.1002/pu.30870
- Publication type:
- Article
6
ECT more effective than ketamine in patients with depression.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 6, doi. 10.1002/pu.30869
- Publication type:
- Article
7
Prediction is easy; change is hard.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 7, doi. 10.1002/pu.30868
- Publication type:
- Article
8
Data suggest patients with OCD can taper SRI after successful therapy.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 4, doi. 10.1002/pu.30867
- Publication type:
- Article
9
Trial‐ineligible patients with schizophrenia have higher risk of adverse outcomes.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 3, doi. 10.1002/pu.30866
- Publication type:
- Article
10
Risk factors for QT prolongation with atypical antipsychotics.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 2, doi. 10.1002/pu.30865
- Publication type:
- Article
11
Ketamine shows no significant effect on PTSD symptoms in military.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 1, doi. 10.1002/pu.30864
- Publication type:
- Article
12
Ketamine infusions promote abstinence in patients with alcohol use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 1, doi. 10.1002/pu.30863
- Publication type:
- Article